title: [Management of ventilator acquired pneumonia].
abstract: Ventilator-associated pneumonia occurs in the evolution of 8 to 70% of patients in the Intensive Care Unit. It is the main site of nosocomial infection for mechanically ventilated patients. Nosocomial pneumonia represents an important cause of morbidity and mortality, despite progresses in antibiotic prescription, use of intensive care and prevention. This review is based on the ATS guidelines, and reviews epidemiology, diagnosis and treatment of ventilator-acquired pneumonia, in non-immunocompromised adults.
authors.affiliation: Département d'anesthésie et de réanimation, CHU Nord, boulevard Pierre-Dramard, 13915 Marseille cedex 20, France. ioanna.boyadjiev@ap-hm.fr
authors.forename: I
authors.initials: I
authors.lastname: Boyadjiev
authors.forename: M
authors.initials: M
authors.lastname: Leone
authors.forename: F
authors.initials: F
authors.lastname: Garnier
authors.forename: J
authors.initials: J
authors.lastname: Albanèse
authors.forename: C
authors.initials: C
authors.lastname: Martin
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003422:Critical Care; D003428:Cross Infection / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D017408:Guidelines as Topic; D006801:Humans; D011014:Pneumonia / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000382:microbiology* / Q000628:therapy*; D012121:Respiration, Artificial / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents